A randomized, open-label, expanded access study of daily CellCept [mycophenolate mofetil] combined with a reduced daily dose of cyclosporine versus a full dose of cyclosporine on evolution of renal function in kidney transplant recipients with impaired renal function.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Ciclosporin; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms REFERENCE
- Sponsors Roche
- 07 Feb 2007 Status change
- 27 Jun 2006 New trial record.